KOPN 10-K & 10-Q changes, risk factors and insider trading
Kopin Corp. · Nasdaq · Semiconductors & Related Devices · CIK 771266 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
Largest changes
We have experienced a history of losses, have a significant accumulated deficit, have had negative cash flow from operating activities in fiscal yearssee in full comparison2024, 2023,2025 and2022,2024, and expect to have negative cash flow from operating activities in fiscal year2025.2026. Since inception, we have incurred significant net operating losses. As of December28,27,2024,2025, we had an accumulated deficit of$402.0$399.5 million. At December28,27,20242025 and December30, 2023,28, 2024, we had$36.6$61.6 million and$17.9$36.6 million of cash and cash equivalents, including restricted cash, and marketable securities, respectively. For the years20242025 and2023,2024, net cash used in operating activities was$14.2$15.5 million and$15.3$14.2 million, respectively. The increase in our cash and cash equivalents and marketable securities is primarily due to gross proceeds of $33.9 million received from the sale of 43.0 million shares of common stock and the pre-funded warrants to purchase up to 4,000,000 shares of common stock at a public offering price of $0.65 pershare.share,Weandhavenetaccruedproceeds$24.8of approximately $38.1 millionfor a litigation issue and asfrom aresultprivateweplacementhavefundraisingconcludedactivitythatforthere19,545,950 sharesisofsubstantialitsdoubtcommonaboutstock,ourparabilityvalueto$0.1continueperasshare at agoing concern within one year following the issuanceprice ofthis$2.10annualperreport.share, We plan to continue to invest in research and development even during periods when we are not profitable, which may result in our incurring losses from operations and negative cash flow. If we do not soon achieve and maintain positive cash flow and profitability, our financial condition will ultimately be materially and adversely affected, and we will be required to raise additional capital. We may not be able to raise any necessary capital on commercially reasonable terms or at all. If we fail to achieve or maintain profitability on a quarterly or annual basis within the timeframe expected by investors, the market price of our common stock may decline.
The Sarbanes-Oxley Act of 2002 and SEC rules require that management annually report on the effectiveness of our internal control over financialsee in full comparisonfinancialreporting and our disclosure controls and procedures. As more fully described within Item 9A, “Controls and Procedures,” of this Annual Report on Form 10-K,inmanagement determined that thefourth quarter of 2024 management identifiedmaterial weaknesses in internal control over financial reporting previously identified in our 2024 Annual Report on Form 10-K had not been fully remediated and identified an additional material weakness in internal control over financial reporting. As a result, our Chief Executive Officer and Chief Financial Officer concluded that our internal controls over financial reporting were not effective as of December28,27,2024.2025. The specific material weaknesses are described in Part II - Item 9A. “Controls and Procedures” of this2024Annual Report on Form 10-K in “Management’s Report on Internal Control over Financial Reporting.” A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements would not be prevented or detected. We cannot assure you that additional material weaknesses in our internal control over financial reporting will not be identified in the future. Any failure to maintain or implement required new or improved controls, or any difficulties we encounter in their implementation, could result in additional material weaknesses, or could result in material misstatements in our financial statements, which could cause us to fail to meet our reporting obligations or cause investors to lose confidence in our reported financial information, leading to a decline in our stock price.The material weaknesses did not result in any identified misstatements to the December 28, 2024, audited financial statements, nor with respect to the financial statements for any previously reported period.
“On February 20, 2026, the U.S. Supreme Court issued a ruling striking down certain tariffs previously imposed under the International Emergency Economic Powers Act. It remains uncertain how this decision will affect the existing tariffs or whether additional tariffs will be imposed under other laws. …”see in full comparison
Changes in government trade policies may increase the cost of our products, which may materially adversely affect our sales or profitability. We depend on a Taiwanese foundry for the manufacture of integrated circuits for our AMLCD display products and on Chinese, Korean, and European foundries for our OLED display products. In recent years the U.S. has imposed, among other actions, new or higher tariffs, including those that have been or may be imposed by thesee in full comparisonnewcurrent presidential administration in the U.S. on specified imported products originating from China in response to what it characterizes as unfair trade practices, and China has responded by proposing or implementing new or higher tariffs on specified products imported from the U.S. Tariffs on components that we import from China or other nations that have imposed, or may in the future impose, tariffs have in some cases and may in the future cause our expenses to increase, which would adversely affect our profitability unless we were able to exclude our products from the tariffs or we raise prices for our products, which may result in our products becoming less attractive relative to products offered by our competitors. In addition, tariffs and international trade arrangements may continue to change, potentially without warning and to an extent that is difficult to predict. Accordingly, future actions or escalations by either the U.S. or China that affect trade relations may also affect our business or that of our suppliers or customers, and we cannot provide any assurances as to whether such actions will occur or the form that they may take. Moreover, it is uncertain to what extent, if any, the U.S. tariffs on components that we import from China will affect the Taiwanese foundries on which we depend, in part because many Taiwanese foundries conduct parts of their manufacturing in China. Kopin has completed and continues to transition several OLED device deposition steps to European supply chain partners for U.S.DoDDoW source of supply requirements and duplicity to reduce the risk of Chinese supply and potential tariffs.
Our business could suffer if we fail to recruit and retain key personnel. To continue to provide quality products in our rapidlysee in full comparisonrapidlychanging business, we believe it is important to retain and recruit personnel with experience and expertise relevant to our business. Our success depends in large part upon several key management and technical employees. The loss of the services of one or more key employees, including Mr. Murray, our President and Chief Executive Officer, could seriously impede our success. We do not maintain any “key-man” insurance policies on Mr. Murray or any other employees.In addition, due to the level of technical and marketing expertise necessary to support our existing and new customers, our success will depend upon our ability to recruit and retain highly skilled management, technical, and sales and marketing personnel. Competition for highly skilled personnel is intense and there may be only a limited number of people with the requisite skills to serve in these positions.Due to the competitive nature of the labor markets in which we operate, we may be unsuccessful in attracting and retaining these personnel. Our inability to attract and retain key personnel could adversely affect our ability to develop and manufacture our products.
We may be unable to manufacture our products cost effectively to meet contractual specifications or customer requirements. Our products are required to meet specifications agreed to in purchase orders and related agreements with our customers. Our ability to produce products which meet these specifications is dependent onsee in full comparisonanumerousnumber of factors includingincluding, but not limitedtoto, our manufacturing processes and our vendors providing raw materials that meet the specifications we have agreed to with them. In addition, while there may be agreement with our customers on the specifications there may be ambiguity with the method to measure compliance with meeting the specifications. When we commence production of new products, we normally go through a period of low production efficiency as we modify our production processes for higher volumeoutputoutput,andresultingtraininmorehigherproduction employees on how to make the product. Low production efficiency means that the cost to make the product is more than what we anticipated when we accepted the purchase order from the customer.costs. In addition, after we commence selling our products customers may request changes to the products which may also result inthelow productionefficiency starting again.efficiency. We currently have several new products and new product configurations going to production. If the products we deliver are found to have undetected defects or latent defectswhenuponwe ship them,shipment, we may incur the cost to recall the products. Product recalls and product liability and warranty claims can result in significant damages and costs, including fines, as well as other harm to our business. If we are unable to manufacture our products cost effectively, our revenue and ability to obtain profitability will be adversely affected.
Full comparison: every changed paragraph (31)
We
operate in a changing global environment that involves numerous known and unknown risks and uncertainties that could materially adversely
affect our financial condition, results of operations, cash flows, and competitive position. Accordingly, our business and financial
results are subject to a number of risks and uncertainties, including those set forth below. Additional risks and uncertainties that
are not currently known to us or that we currently do not believe to be material may also negatively affect our business and financial
results. The risk factors set forth below describe what we believe to be the material risks and uncertainties related to our financial
condition, results of operations, cash flows, and competitive position. We have included the risk factors below without any reflection
on the relative importance of, or likelihood of, any particular risk factor.
We
have experienced a history of
losses, have a significant accumulated deficit, have had negative cash flow from operating activities
in fiscal years 2024, 2023,2025 and 2022, 2024,
and expect to have negative cash flow from operating activities in fiscal year 2025.2026. Since
inception, we have incurred significant
net operating losses. As of December 28,27, 2024,2025, we had an accumulated deficit of $402.0
$399.5 million. At December 28,27, 20242025 and December 30, 2023,28,
2024, we had $36.6$61.6 million and $17.9$36.6 million of cash and cash equivalents, including
restricted cash, and marketable securities, respectively.
For the years 20242025 and 2023,2024, net cash used in operating activities was
$14.2 $15.5 million and $15.3$14.2 million, respectively. The increase in
our cash and cash equivalents and marketable securities is primarily
due to gross proceeds of $33.9 million received from the sale of
43.0 million shares of common stock and the pre-funded warrants to
purchase up to 4,000,000 shares of common stock at a public offering
price of $0.65 per share.share, Weand havenet accruedproceeds $24.8of approximately $38.1 million for a
litigation issue and asfrom a resultprivate weplacement havefundraising concludedactivity thatfor there19,545,950
shares isof substantialits doubtcommon aboutstock, ourpar abilityvalue to$0.1 continueper asshare at a going concern within one year following the issuanceprice of this$2.10 annualper report.share, We plan
to continue to invest in research and development
even during periods when we are not profitable, which may result in our incurring
losses from operations and negative cash flow. If we
do not soon achieve and maintain positive cash flow and profitability, our
financial condition will ultimately be materially and adversely
affected, and we will be required to raise additional capital. We
may not be able to raise any necessary capital on commercially reasonable
terms or at all. If we fail to achieve or maintain
profitability on a quarterly or annual basis within the timeframe expected by investors,
the market price of our common stock may
decline.
Raising
additional funds by
issuing securities may cause dilution to our existing stockholders or restrict our operations. To the extent
that we raise additional
capital by issuing equity securities, the share ownership of existing stockholders will be diluted. The terms
of any financing may adversely
affect the holdings or the rights of our stockholders and the issuance of additional securities, whether
equity or debt, or the possibility
of such issuance, may cause the market price of our shares to decline. We may sell shares or other
securities in other offerings at a
price per share that is less than the prices per share paid by other investors, and investors purchasing
shares of our common stock or
other securities in the future could have rights superior to existing stockholders. The sale of additional
equity or convertible securities
would dilute all of our stockholders, and the terms of these securities may include liquidation or other
preferences that adversely affect
our existing stockholders.
The
Sarbanes-Oxley Act of 2002 and SEC rules require that management annually report on the effectiveness of our internal control over
financial financial
reporting and our disclosure controls and procedures. As more fully described within Item 9A, “Controls and
Procedures,”
of this Annual Report on Form 10-K, inmanagement determined that the fourth quarter of 2024 management identified material weaknesses in internal control over financial reporting previously identified in our
2024 Annual Report on Form 10-K had not been fully remediated and identified an additional material weakness in internal control over
financial reporting.
As a result, our Chief Executive Officer and Chief Financial Officer concluded that our internal controls over financial
reporting were
not effective as of December 28,27, 2024.2025. The specific material weaknesses are
described in Part II - Item 9A. “Controls and
Procedures” of this 2024Annual Report on Form 10-K in “Management’s Report on
Internal Control over Financial Reporting.” A material
weakness is a deficiency, or a combination of deficiencies, in internal
control over financial reporting, such that there is a reasonable
possibility that a material misstatement of our annual or interim
consolidated financial statements would not be prevented or detected.
We cannot assure you that additional material weaknesses in
our internal control over financial reporting will not be identified in the
future. Any failure to maintain or implement required
new or improved controls, or any difficulties we encounter in their implementation,
could result in additional material weaknesses,
or could result in material misstatements in our financial statements, which could cause
us to fail to meet our reporting
obligations or cause investors to lose confidence in our reported financial information, leading to
a decline in our stock price. The material weaknesses did not result in any identified misstatements to the December 28, 2024, audited
financial statements, nor with respect to the financial statements for any previously reported period.
We
are in the process of developing and implementing our remediation plan for the identified material weaknesses, and we expect that this
work will continue in 2025.2026. There can be no assurance, however, as to when the remediation plan will be fully developed, when it will
be fully implemented and/or the cost of its implementation. Until our remediation plan is fully implemented, we will continue to devote
significant time and attention to these efforts. If we do not complete our remediation in a timely fashion, or at all, or if our remediation
plan is inadequate, there is a risk that we will be unable to timely file future periodic reports with the SEC and/or that our future
financial statements could contain undetected errors. Until the remediation plan is complete and implemented, we will rely upon additional
interim control procedures prescribed by management, including the utilization of manual mitigating control procedures to help ensure
that we fairly state our financial statements in all material respects. However, the establishment of these interim controls does not
provide the same degree of assurance as a fully remediated control environment. For more information relating to our internal control
over financial reporting and disclosure controls and procedures, and the remediation plan that we have undertaken, see Part II - Item
9A. “Controls and Procedures” of this 2024Annual Report on Form 10-K.
We
may be unable to manufacture our products cost effectively to meet contractual specifications or customer requirements. Our products
are required to meet specifications agreed to in purchase orders and related agreements with our customers. Our ability to produce products
which meet these specifications is dependent on anumerous number of factors includingincluding, but not limited toto, our manufacturing processes and our
vendors providing raw materials that meet the specifications we have agreed to with them. In addition, while there may be agreement with
our customers on the specifications there may be ambiguity with the method to measure compliance with meeting the specifications. When
we commence production of new products, we normally go through a period of low production efficiency as we modify our production processes
for higher volume outputoutput, andresulting trainin morehigher production employees on how to make the product. Low production efficiency means that the cost
to make the product is more than what we anticipated when we accepted the purchase order from the customer.costs. In addition, after we commence
selling our products customers may request changes to the products which may also result in the low production efficiency starting again.efficiency.
We currently have several new products and new product configurations going to production. If the products we deliver are found to have
undetected defects or latent defects whenupon we ship them,shipment, we may incur the cost to recall the products. Product recalls and product liability
and warranty claims can result in significant damages and costs, including fines, as well as other harm to our business. If we are unable
to manufacture our products cost effectively, our revenue and ability to obtain profitability will be adversely affected.
Our
revenues and cash flows could be negatively affected if sales of our display products for defense applications significantly decline
or the current defense development programs are either cancelled or ultimately do not result in future product sales. The sale of
our display products to the military for use in thermal weapon sights and avionic helmets has been a primary source of our defense revenues
and cash flows over the last several years. We currently are included in the Family Weapon Sight (“FWS”) Individual program
and the Joint Strike Fighter (F-35) jet fighter program. In 2023 and 2024, we experienced quality issues with the products we supplied
for the FWS-I program. These quality issues resulted in suspension of shipments to our customer at various times during 2023 and 2024
as we made modifications to our production processes. We are continuing to make modifications to our production processes as we resolve
certain issues. We are in development and qualification of additional defense programs related to avionic helmets, armored vehicles and
soldier rifle scopes. Our ability to generate revenues and cash flow from sales to the U.S. military and our customers depends on our
Display products remaining qualified in the F-35 Joint Strike Fighter, FWS and other U.S. defense programs, our customers continuing
to serve as the suppliers for those programs, and on the U.S. Government/military funding these programs. We may not be awarded contracts
for the systems we are in qualification for, and for the systems we are qualified for, we may only be awarded a portion of the program
as the U.S. military looks to have multiple sources when possible. Even if our products qualify for these programs, the U.S. Government
can opt to change suppliers, in which case demand for our products could be negatively affected. In addition, the government could postpone
or cancel these programs. We believe the DoDDoW is evaluating alternative display technologies for the F-35 Strike Fighter program and other
defense programs, and we will need to develop and qualify any replacement display technologies. Our ability to generate revenues and
cash flow from sales to the U.S. military also depends on winning contracts over our competitors. If we are unable to be qualified into
new U.S. defense programs, remain qualified in existing programs, or win orders against our competition, or if defense programs are not
funded, then our ability to generate revenues and achieve profitability and positive cash flow will be materially and negatively impacted.
A
decline in
the U.S. Government defense budget, changes in spending or budgetary priorities, a prolonged U.S. Government shutdown or
delays in
contract awards may significantly and adversely affect our future revenues, cash flow and financial results. In
addition to the
Anti-Deficiency Act, in recent years U.S. Government appropriations have been affected by larger U.S. Government
budgetary issues,
including reductions or shifts in the capital resources or government funding, and related legislation. As a
result, DoDDoW funding
levels have fluctuated and have been difficult to predict. Future spending levels are subject to a wide range of
factors, including
Congressional action and changes to governmental policies and programs, including loans, grants, guarantees and
other subsidies, and
changes to government spending policies, including shifts in funding priorities. In addition, in recent years
the U.S. Government
has been unable to complete its budget process before the end of its fiscal year, resulting in both a government
shutdown and
continuing resolutions to extend sufficient funds only for U.S. Government agencies to continue operating.
Additionally, Most recently,if the
federal government was shut down due to a lack of funding for over one month between late 2018 and early 2019. Additionally, the
national debt has recently threatened to reachreaches the statutory debt ceiling in 2024,future
years, and such an event in future yearsit could result in
the U.S. Government defaulting on its debts.
Most
of our defense
sales are on a fixed-price basis, which could subject us to losses if there are cost overruns. Under a
fixed-price contract, we receive
only the amount indicated in the contract, regardless of the actual cost to produce the goods.
While firm fixed-price contracts allow
us to benefit from potential cost savings, they also expose us to the risk of cost overruns.
If the initial estimates that we use to
calculate the sales price and the cost of performing the work prove to be incorrect, we
could incur losses. We have had situations where
we have underestimated the cost of a program and incurred losses in fulfilling the contract. As discussed above, we are seeing a global
shortage of semiconductors and other raw materials which is resulting
in a significant increase in some raw material prices. In addition,
the U.S. recently experienced inflation levels not seen in many
years which drove higher labor costs and there is an expectation that
tariffs may result in additional inflation in the future. Some
of our contracts have specific provisions relating to cost, scheduling,
and performance. If we fail to meet the terms specified in
those contracts, then our cost to perform the work could increase, which would
adversely affect our financial position and results
of operations. Some of the contracts we bid on have Indefinite Delivery, Indefinite
Quantity (“IDIQ”) provisions. This
means we are bidding a fixed price but are not assured of the quantity the government
will buy or when it will buy during the term
of the contract. This means we are exposed to the risk of price increases for labor, overhead
and raw materials during the term of
the contract. We may incur losses on fixed-price and IDIQ contracts that we had expected to be profitable,
or such contracts may be
less profitable than expected, which could have a material adverse effect on our business, financial condition,
results of
operations, and cash flows.
Changes
in government trade
policies may increase the cost of our products, which may materially adversely affect our sales or profitability.
We depend on a Taiwanese
foundry for the manufacture of integrated circuits for our AMLCD display products and on Chinese, Korean,
and European foundries for our
OLED display products. In recent years the U.S. has imposed, among other actions, new or higher tariffs,
including those that have been
or may be imposed by the newcurrent presidential administration in the U.S. on specified imported products
originating from China in response
to what it characterizes as unfair trade practices, and China has responded by proposing or implementing
new or higher tariffs on specified
products imported from the U.S. Tariffs on components that we import from China or other nations that
have imposed, or may in the future
impose, tariffs have in some cases and may in the future cause our expenses to increase, which would
adversely affect our profitability
unless we were able to exclude our products from the tariffs or we raise prices for our products,
which may result in our products becoming
less attractive relative to products offered by our competitors. In addition, tariffs and international
trade arrangements may continue to change, potentially without warning and to an extent that is difficult to predict. Accordingly, future
actions or escalations by either the U.S. or China
that affect trade relations may also affect our business or that of our suppliers
or customers, and we cannot provide any assurances as
to whether such actions will occur or the form that they may take. Moreover, it
is uncertain to what extent, if any, the U.S. tariffs
on components that we import from China will affect the Taiwanese foundries on
which we depend, in part because many Taiwanese foundries
conduct parts of their manufacturing in China. Kopin has completed and continues
to transition several OLED device deposition steps to
European supply chain partners for U.S. DoDDoW source of supply requirements and duplicity
to reduce the risk of Chinese supply and potential
tariffs.
On February 20, 2026, the U.S. Supreme Court issued a ruling striking down certain tariffs previously imposed under the International Emergency Economic Powers Act. It remains uncertain how this decision will affect the existing tariffs or whether additional tariffs will be imposed under other laws. Significant uncertainty exists regarding the duration of existing and newly announced tariffs, potential changes or pauses to such tariffs, tariff levels, and whether further additional tariffs or other retaliatory actions may be imposed, modified, or suspended, and the impacts of such actions on our business. We are continuing to monitor and evaluate these developments and assess their potential negative effects on our business, financial condition, and results of operations.
Our
business business
and financial performance may be adversely affected by cyber-attacks on information technology infrastructure and products,
as well
as changes in cybersecurity and if our information technology security systems were infiltrated and confidential and/or
proprietary proprietary
information were taken, we could be subject to fines, lawsuits and loss of customers. Significantly larger organizations with
much greater resources than us have been the victim of cybercrimes. We routinely receive emails
probing our Internet security, and
our Internet security systems have detected outside organizations attempting to install Trojan
virus software packages in our
systems. We rely on our electronic information systems to perform routine transactions to run our
business. We transact business
over the Internet with customers, vendors and our subsidiaries and have implemented security measures
to protect against
unauthorized access to this information. We have also implemented security policies that limit access via the
Internet from the
Company to the outside world based on the individual’s position in the Company. We routinely receive
security patches from
software providers for the software we use. Our primary concerns are inappropriate access to personnel
information, information
covered under the International Traffic in Arms Regulation, product designs and manufacturing information,
financial information and
our intellectual property, trade secrets and know-how. Our business may be impacted by disruptions to our
own or third-party
information technology (“IT”) infrastructure, which could result from, among other causes,
cyberattacks on or failures of such
infrastructure or compromises to its physical security. Cybersecurity threats are continuously
evolving and include, but are not
limited to, both attacks on our IT infrastructure and attacks on the IT infrastructure of our
customers, suppliers, subcontractors
and other third parties with whom we do business routinely, both on premises and in the cloud,
attempting to gain unauthorized
access to our confidential, proprietary, or otherwise protected information, classified information,
or information relating to our
employees, customers and other third parties, or to disrupt our systems or the systems of third
parties. We are also exposed to the
risk of insider threat attacks. Any such attacks could disrupt our systems or those of third
parties, impact business operations,
result in unauthorized release of confidential, proprietary, or otherwise protected
information, and corrupt our data or that of
third parties. The threats we face are continuously evolving and vary in degree of
severity and sophistication. These threats
include advanced persistent threats from highly organized adversaries, including but not
limited to cyber criminals, nation states
and so-called hacktivists, particularly those adverse to the security interests of the
U.S. and its allies, which target us and
other defense contractors. These types of threats are related to the geopolitical
environment and have, therefore, grown in number
due to recent geopolitical conflicts. In addition, because of the rapid pace of
technological change, we and our customers,
suppliers, subcontractors and other third parties with whom we conduct business continue
to rely on legacy systems and software,
which can be more vulnerable to cyber threats and attacks. Moreover, we, like other
companies, see an unprecedented number of
previously unknown vulnerabilities, for which there are no known mitigations being
revealed by new attacks. Further, the
sophistication, availability and use of artificial intelligence by threat actors present an
increased level of risk. Due to the
evolving threat landscape, we have experienced and expect to continue to experience more
frequent and increasingly advanced
cyber-attacks. In addition, changes in domestic and international cybersecurity-related laws and
regulations have expanded
cybersecurity-related compliance requirements, and cybersecurity regulatory enforcement activity has
grown. We expect the regulatory
environment to continue to evolve, and staying apace with these regulatory changes could increase
our operational and compliance
expenditures and those of our suppliers, and lead to new or additional information technology and
product development expenses. We
also face reputational, litigation and financial risks in relation to potential required
disclosures and increased risk of
enforcement. We continue to make investments and adopt measures designed to enhance our
protection, detection, response, and
recovery capabilities, and to mitigate potential risks to our technology, products, services
and operations from potential
cybersecurity threats, as well as to comply with evolving regulations. However, given the
unpredictability, nature and scope of
cyber-attacks, it is possible that we are unable to defend against all cyber-attacks, that
potential vulnerabilities could go
undetected and persist in the environment for an extended period, or that we may otherwise be
unable to mitigate customer losses and
other potential consequences of these attacks. In some cases, we must rely on the safeguards
put in place by our customers,
suppliers, subcontractors and other third parties to protect against and report cyber threats and
attacks. We could potentially be
subject to production downtimes, operational delays, other detrimental impacts on our operations or
ability to provide products and
services to our customers, the compromise of confidential information, intellectual property or
otherwise protected information,
misappropriation, destruction or corruption of data, security breaches, other manipulation or
improper use of our or third-party
systems, networks or products, financial losses from remedial actions, loss of business, or
potential liability, penalties, fines
and/or damage to our reputation. Any of these could have a material adverse effect on our
competitive position, results of
operations, financial condition or liquidity. Due to the evolving nature of such risks, the impact
of any potential incident cannot
be predicted.
Supply
shortages have and could continue to impair the quality, reduce the availability or increase the cost of raw materials, which could harm
our business. We rely on third-party independent contractors for certain integrated circuit chip sets, backlights, and other critical
raw materials such as special glasses, wafers, and chemicals. Lead times for the parts and components that we order vary significantly
and depend on factors such as manufacturing cycle times, manufacturing yields, and the availability of raw materials used to produce
the parts or components. The semiconductor industry has been and continues to experience a shortage of semiconductor components. We have
experienced intermittent shortages of raw materials, which has affected our ability to manufacture and ship units. These shortages have
also resulted in an increase in the cost of raw materials and semiconductor components. Our products sold for defense applications go
through an expensive and long qualification period before the government will acceptaccepts the products. Once the product for a defense application
is accepted there are restrictions on our ability to substitute a different raw material or component for the one used in the qualification
of the product. If these shortages were to further affect our supply of raw materials, our ability to manufacture and distribute our
products could continue to be adversely affected, which in turn would adversely affect our results of operations or financial condition.
Geopolitical
tensions and any conflicts resulting therefrom may negatively affect our ability to source materials and components required to manufacture
manufacture our products. We depend principally on a Taiwanese foundry for the fabrication of integrated circuits for our AMLCD
defense display
products. We use a Chinese foundry for the deposition process in creating our OLED displays. Our reliance on these
foundries involves
several risks, including reduced control over availability, capacity utilization, delivery schedules,
manufacturing yields, and costs.
Geopolitical changes in China-Taiwan or China-U.S. relations could disrupt these foundries’
operations and cause these risks to
materialize, which would adversely affect our ability to manufacture our display products. If
these foundries were to become unable to
provide the required capacity, services or quality on a timely basis due to a military or
other form of conflict, geopolitical tensions,
including in Ukraine, the Middle East, China, Taiwan and other regions, financial
market volatility and disruption, inflationary concerns,
changes in tax laws and regulations, interest and currency exchange rates,
uncertain economic conditions in the United States and abroad,
and additionaluncertainties with respect to tariffs, including those imposed or that may be
imposed by the newcurrent presidential administration in the U.S., or other reasons
relating thereto, we may not be able to manufacture and
ship our display products, or we may be forced to manufacture them in limited
quantities until replacement foundry services can be
obtained. Furthermore, we cannot assure that we would be able to establish alternative
manufacturing and packaging relationships on
acceptable terms or at all.
We
are in the process of transitioning from using a Chinese deposition foundry to a European foundry for certain OLED products for defense
applications. We depend principally on a Chinese foundry for the deposition process in creating our OLED displaysdisplays, but we are in the
process of having the deposition process performed by a European foundry. If we are unsuccessful in executing our transition plan or
if the transition is significantly delayed, our ability to manufacture and distribute our products could continue to be adversely affected,
which in turn would adversely affect our results of operations or financial condition.
We
generally do not have long-term contracts with our customers, which makes forecasting our revenues and operating results difficult. We
generally do not enter into long-term agreements with our customers obligating them to purchase our products. Our business is characterized
by short-term purchase orders with shipment schedules within one year, and we generally permit orders to be cancelled or rescheduled
before before
shipment without significant penalty. As a result, our customers may cease purchasing our products at any time, which makes forecasting
our revenues difficult. In addition, due to the absence of a substantial non-cancellable backlog, we typically plan our production and
inventory levels based on internal forecasts of customer demand, which are highly unpredictable and can fluctuate substantially. The
uncertainty ofabout product orders makes it difficult for us to forecast our sales and allocate our resources in a manner consistent with
our actual sales. Moreover, our expense levels and the amounts we invest in capital equipment and new product development costs are based
in part on our expectations of future sales and, if our expectations regarding future sales are inaccurate, we may be unable to reduce
costs in a timely manner to adjust for sales shortfalls, and our results of operations and financial condition could be materially adversely
affected.
Our
customers who purchase display products for defense applications typically incorporate our products into their products, which are
sold to the U.S. Government under contracts. U.S. Government contracts generally are not fully funded at inception and may be
terminated or modified prior to completion, which could adversely affect our business. Congress funds much of the federal budget
on an annual basis, and Congress often does not provide agencies with all the money requested in their budget. Many of our
customers’ contracts cover multiple years and, as such, are not fully funded at the contract award. If appropriations from
Congress or a U.S.
Government agency chooses to spend money on other programs, including as a result of changes to governmental policies and programs
imposed or that may be imposed by the new presidential administration in the U.S.,change, our customers’ contracts may be terminated
for convenience. The Anti-Deficiency
Act prohibits involving the government in any obligation to pay money before funds have been
appropriated for that purpose, unless
otherwise allowed by law. Therefore, the Anti-Deficiency Act indirectly regulates how agencies
award our contracts and pay our
invoices. Federal government contracts generally contain provisions that provide the federal
government rights and remedies not
typically found in commercial contracts, including provisions permitting the federal government
to, among other things: terminate
our existing contracts; modify some of the terms and conditions in our existing contracts; subject
the award to protest or challenge
by competitors; suspend work under existing multiple year contracts and related delivery orders;
and claim rights in technologies
and systems invented, developed or produced by us.
We may be unable to adequately control purchase pricing of certain critical materials, which may materially adversely affect our sales or profitability. We have no long-term pricing contracts on foundry wafers and certain other materials that represent a significant portion of our product bill of material costs. We cannot provide assurance against supplier price increases that negatively impact on the cost of producing products, which may adversely affect sales or profitability. Finding and/or qualifying a more cost-effective replacement supplier may take significant time.
The
markets in which we operate are highly competitive and rapidly changing and we may be unable to compete successfully. There are several
companies that develop or may develop products that compete in our targetedtarget markets. The individual components that we offer for sale
(displays, optical lenses, backlights and ASICs) are also offered by companies whose sole business focuses on that individual component.
For example, there are companies whose sole business is to sell optical lenses. Accordingly, our strategy requires us to develop technologies
and to compete in multiple markets. Some of our competitors are much larger than we are and have significantly greater financial, development
and marketing resources than we do. The competition in these markets could adversely affect our operating results by reducing the volume
of the products we sell or the prices we can charge. These competitors may be able to respond more rapidly than us to new or emerging
technologies, including artificial intelligence technologies, or changes in customer requirements. They may also devote greater resources
to the development, promotion and sale of their
products than we do.
Our
success will depend substantially
upon our ability to enhance our products and technologies and to develop and introduce, on a timely
and cost-effective basis, new products
and features that meet changing customer requirements and incorporate technological enhancements.
For example, we believe there is a growing
demand for microLED display products and if microLEDs can be successfully commercialized they
may reduce demand for our AMLCD and OLED
displays. We are investing in the development of microLED displaydisplays and the cost of such development
we believe will be substantial. We
are competing against larger companies with greater resources than us in the development of microLED
displays. If we are unable to develop
new products and enhance functionalities or technologies to adapt to these changes or secure any
necessary regulatory approvals to roll
out such new technologies on a timely basis, our business may suffer. In addition, our use of
new or emerging technologies, such as artificial intelligence, may result in substantial integration and maintenance costs and may expose
us to additional
risks. For example, the content, analyses, or recommendations generated by artificial intelligence programs, if deficient,
inaccurate, inaccurate,
or biased, could adversely impact our business, financial condition, and operational results, as well as our reputation.
Moreover, ethical
concerns associated with artificial intelligence could lead to brand damage, competitive disadvantages, or legal repercussions.
Any problems
with our implementation or use of artificial intelligence or other technological advancements could also negatively impact on
our business
or results of our operations.
Disruptions
of our production could adversely affect our operating results. If we were to experience any significant disruption in the operation
of our facilities, we would be unable to supply our products to our customers. Many of our sales contracts include financial penalties
for late delivery. In the past, we have experienced power outages at our facilities, which ranged in duration from one to four days.
We have certain critical pieces of equipment necessary to operate our facilities that are no longer offered for salesale, and we may not have
service contracts or spare parts for the equipment. Additionally, as we introduce new equipment into our manufacturing processes, our
display products could be subject to especially wide variations in manufacturing yields and efficiency. We may experience manufacturing
problems that would result in delays in product introduction and delivery or yield fluctuations.
A disruption to our information technology systems could significantly impact on our operations, revenue and profitability. Our data processing systems and our Enterprise Resource Planning (“ERP”) software are cloud-based and hosted by third parties. We also use software packages that are no longer supported by their developer. We have experienced short-term (i.e., a few days) interruptions in our Internet connection. An interruption of the third-party systems or the infrastructure that allows us to connect to the third-party systems for an extended period may affect our ability to operate our business and process transactions, which could result in a decline in sales and affect our ability to achieve or maintain profitability.
We
may not achieve some or all of the anticipated benefits of our equity investments. On December 28,27, 2024,2025, we had equity investments
in companies totallingtotaling $3.6$12.4 million, where we have limited, if any, control over their governance, financial reporting and operations.
As a result, we face certain operating, financial and other risks relating to these investments, including risks related to the financial
strength of the investments. We are required to periodically review the value of these investments for impairment. For example, in the
third quarter of 2024,2025, we reviewed the financial condition and other factors of our investment in a customer and as a result, we recorded
an impairment charge of $0.7$0.4 million to reduce the carrying value of our investment. These investments may not contribute to our earnings
or cash flows.flow. In addition, these investments may be required to raise additional capital, which may result in our ownership percentage
being decreased.
If
we are unable to obtain or maintain existing software license relationships or other relationships relating to the intellectual property
we use, our ability to grow revenue and achieve profitability and positive cash flow may be negatively affected. Our headset systems
include software that we license from other companies. Should we violate the terms of a license, our license could be cancelled. Companies
may decide to stop supporting the software we license,are licensing, or new versions of the software may not be compatible with our software, which
would require us to rewrite our software, which we may not be able to do. Moreover, the license fees we pay may be increased, which would
negatively affect our ability to achieve profitability and positive cash flow.
We
may incur substantial costs in defending our intellectual property and may not be successful in protecting our intellectual property
and proprietary rights. Our success depends in part on our ability to protect our intellectual property and proprietary rights. We
rely on a combination of patents, trademarks, copyrights, trade secrets, nondisclosure agreements, IT security systems, internal controls
and compliance systems, and other measures to protect our intellectual property. We also rely on nondisclosure agreements, confidentiality
obligations in contracts, IT security systems, and other measures to protect certain customer and supplier information and intellectual
property that we have in our possession or to which we have access. We have obtained certain domestic and foreign patentspatents, and we intend
to continue to seek patents on our inventions when appropriate. We also attempt to protect our proprietary information with contractual
arrangements and under trade secret laws. Our employees and consultants generally enter into agreements containing provisions with respect
to confidentiality and the assignment of rights to us for inventions made by them while in our employ or consulting for us. These measures
may not adequately protect our intellectual property or proprietary rights. Existing trade secret, trademark and copyright laws afford
only limited protectionprotection, and our patents could be invalidated, held to be unenforceable or circumvented. Moreover, the laws of certain
foreign countries in which our products are or may be manufactured or sold may not provide full protection of our intellectual property
rights. Misappropriation of our technology and the costs of defending our intellectual property rights from misappropriation could substantially
impair our business. If we are unable to protect our intellectual property or proprietary rights, our business may not be successful,
and the price of our common stock may decline.
Our
business could suffer if we fail to recruit and retain key personnel. To continue to provide quality products in our rapidly
rapidly changing business, we believe it is important to retain and recruit personnel with experience and expertise relevant to our
business. Our
success depends in large part upon several key management and technical employees. The loss of the services of one or
more key employees,
including Mr. Murray, our President and Chief Executive Officer, could seriously impede our success. We do not
maintain any “key-man”
insurance policies on Mr. Murray or any other employees. In addition, due to the level of technical and marketing expertise necessary
to support our existing and new customers, our success will depend upon our ability to recruit and retain highly skilled management,
technical, and sales and marketing personnel. Competition for highly skilled personnel is intense and there may be only a limited number
of people with the requisite skills to serve in these positions. Due to the
competitive nature of the labor markets in which we operate,
we may be unsuccessful in attracting and retaining these personnel. Our
inability to attract and retain key personnel could adversely
affect our ability to develop and manufacture our products.
If
we fail to keep pace with changing technologies, we may lose customers. Rapidly changing customer requirements and evolving technologies
and industry standards characterize our industries. To achieve our goals, we need to enhance our existing products and develop and market
new products that keep pace with continuing changes in industry standards, requirements and customer preferences.industry. We may be unable to
bring to market technologies and products that are attractive to our customers, and as a result, our business, financial condition and
results of operations may be materially adversely affected.
We
may incur significant liabilities if we fail to comply with stringent environmental laws and regulations and the ITAR, or if we did not
comply with these regulations in the past. We are subject to a variety of federal, state and local government regulations related
to the use, storage, discharge and disposal of toxic or other hazardous chemicals used in our manufacturing process. We are also subject
to federal International Traffic in Arms Regulations (“ITAR”) laws that regulate the export of technical data and export
of products to
other nations that may use these products for defense purposes. Failure to comply with present or future regulations could
result in
fines, suspension of production, or a cessation of operations. Any failure on our part to control the use of, or adequately
restrict restrict
the discharge of, hazardous substances, or otherwise comply with environmental regulations, could subject us to significant
future liabilities.
Any failure on our part to obtain any required licenses for the export of technical data and/or export of our products
or to otherwise
comply with ITAR, could subject us to significant future liabilities. In addition, we cannot be certain that we have
not violated applicable
laws or regulations in the past, which violations could result in required remediation or other liabilities.
We also cannot be certain
that past use or disposal of environmentally sensitive materials in conformity with the existing environmental
laws and regulations will
protect us from required remediation or other liabilities under current or future environmental laws or regulations.
We
may be unable to modify our products to meet regulatory or customer requirements. From time to time our products display productsare
subject are subject
to new domestic and international requirements, such as the European Union’s Restriction on Hazardous Substances
Directive. Our
customers’ terms and conditions require us to follow “all laws.” If we are unable to comply with these regulations,
we may not be permitted to ship our products, which would adversely
affect our revenue and ability to maintain profitability. In addition,
if we are found to be in violation of laws, we may be subject
to fines and penalties.
We
may be unable to successfully integrate new strategic acquisitions and investments, which could materially adversely affect our
business, business,
results of operations and financial condition. In the past, we have made, and in the future, we may make acquisitions
of, and investments
in, businesses, products and technologies that could complement or expand our business. If we identify an acquisition candidate, weWe may
not be able to
successfully integrate thefuture acquired businesses, productsassets or technologies into our existing business and products. Future
acquisitions could result in potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities,
amortization expenses and write-downs of acquired assets.
Changes
in China’s laws, legal protections or government policies on foreign investment in China may harm our business. Our Chinese
Chinese investments are subject to laws and regulations applicable to foreign investment in China as well as laws and regulations applicable
applicable to foreign-invested enterprises. These laws and regulations frequently change, including as a result of the new
current presidential administration
in the U.S., and their interpretation and enforcement involve uncertainties that could limit the legal
protections available to us. Regulations
and rules on foreign investments in China impose restrictions on the means that a foreign
investor like us may apply to facilitate corporate
transactions we may undertake. In addition, the Chinese legal system is based in
part on government policies and internal rules, some
of which are not published on a timely basis or at all, that may have a
retroactive effect. As a result, we may not be aware of our violation
of these policies and rules until sometime after the
violation. If any of our past operations are deemed to be non-compliant with Chinese
law, we may be subject to penalties. For instance, under the catalogue for the Guidance of Foreign Investment
Industries, some industries
are categorized as sectors that are encouraged, restricted or prohibited for foreign investment. As the
Catalogue for the Guidance of
Foreign Investment Industries is updated every few years, there can be no assurance that China’s
government will not change its
policies in a manner that would render part or all of our investment to fall within the restricted or
prohibited categories. If we cannot
obtain approval from relevant authorities to engage in businesses that have become prohibited or
restricted for foreign investors, we
may be forced to sell our investment if possible. Moreover, uncertainties in the Chinese legal system may
impede our ability to enforce
contracts with our business partners, customers and suppliers, or otherwise pursue claims in
litigation to recover damages or loss of
property, which could adversely affect our business and operations.
Management's Discussion & Analysis (MD&A)
New heading “Consolidation, Variable Interest Entities, and Deconsolidation of Kopin Europe”
Largest changes
Wesee in full comparisonhaveincurredhad netlossesincome of of $2.6 million in fiscal year 2025 and a net loss of $43.9million, $19.7millionand $19.3 million for thein fiscalyearsyear 2024,2023 and 2022, respectively,and net cash outflows from operations of$14.2 million, $15.3$15.5 million and$17.7$14.2 million for the fiscal years ended2024, 20232025 and2022,2024, respectively. Our net cash outflows from operations were partially a result of funding our ongoing investments in research and development which we believe will continue.WeHowever,havethe Company raised approximately $45.8 million during the fiscal year ended December 27, 2025, through the issuance of common stock, pre-funded warrants and preferred stock. Moreover, the Company has posted a bond to satisfy the court’s verdict of $19.7 million in damages and anticipated accrued interest in thepastmattersoldofequityBlueRadiossecuritiesvs.throughKopinanCorporation,at-the-marketInc.offeringshould the Company’s appeal be unsuccessful (refer to Note 14 of our consolidated financial statements for more information). As of December 27, 2025, the Company had $36.4 million cash andincashthe traditionalequivalentsfashion(excludingofrestrictedsignificantcash),equity offerings. Aswhich the Company believes isunablesufficient toconcludesupport itsthat a favorable outcome in this litigation is probableoperations andduesatisfytoits obligations for at least thenet losses and negative cash flows from operations, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern fornext twelve months from theissuancedate ofthese financialthisstatements.filing.Excluding a possible adverse result of the litigation discussed in Note 12 of the consolidated financial statements, weWe estimate we will have sufficient liquidity to fund operations at least through the end of the second quarter of2026.2027. Nonetheless,Nonetheless,we monitor the capital markets on an ongoing basis and may consider raising capital if favorable market conditions develop. If our actual results are less than projected or we need to raise capital for additional liquidity, we may be required to do additional equityfinancings,financing, reduce expenses or enter into a strategic transaction. However, we can make no assurance that we will be able to raise additional capital, reduce expenses sufficiently, or enter into a strategic transaction on terms acceptable to us, or atall.all
“The increase in cash, cash equivalents, and restricted cash for the twelve months ended December 27, 2025 was primarily due to proceeds from the sales of marketable securities of $36.4 million, proceeds from issuance of preferred stock of $6.7 million partially offset by purchases of marketable securities of $15.2 million, cash used in operations of $15.5 million, capital expenditures of $1.4 million and proceeds from the sale of an equity investment of $0.3 million. …”see in full comparison
“The change in cash and cash equivalents and marketable securities was primarily due to the sale of common stock and prefunded warrants of $1.5 million in the fourth quarter of 2024, $25.2 million in the third quarter of 2024 and $7.2 million in the first quarter of 2024 which was partially offset by cash used in operations of $14.2 million. Our cash and cash equivalents and liquidity could be adversely affected by any amounts that become payable in connection with any adverse results from any litigation we are, or may become, involved in.”see in full comparison
“On October 16, 2025, the Company completed a $15 million strategic investment with Theon International Plc. Under the terms of the Agreements, Theon acquired a 49% interest in Kopin’s subsidiary, Kopin Europe Ltd. for $8.0 million and the parties entered into a licensing and development agreement and funding agreements relating to the joint development of military products. In addition, Theon purchased $7.0 million worth of shares of Series A Convertible Preferred Stock, par value $0.01 per share, of the Company (the “Preferred Stock”). …”see in full comparison
“Consolidation, Variable Interest Entities, and Deconsolidation of Kopin Europe”see in full comparison
“Litigation damages were accrued as a result of the April 22, 2024, jury verdict that was entered against the Company awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. On September 5, 2025, Kopin received a judgment from the courts in the BlueRadios litigation awarding BlueRadios $19.7 million in damages but denying permanent injunction and prejudgment interest. This most recent judgment also provides for the accrual of interest of less than $0.1 million per month until the final settlement. …”see in full comparison
Full comparison: every changed paragraph (56)
Our
fixed-price contracts with the U.S. Government or other customers may result in revenue recognized in excess of amounts currently billed.
We disclose the excess of revenues over amounts actually billed as Contract assets and unbilled receivables on the balance sheet. Amounts
billed and due from
our customers are classified as Accounts receivable on the balance sheets. In some instances, the U.S. Government
retains a small portion
of the contract price until completion of the contract. The portion of the payments retained until final contract
settlement is not considered
a significant financing component because the intent is to protect the customer. For contracts with the
U.S. Government, we typically
receive interim payments either as work progresses, by achieving certain milestones or based on a schedule
in the contract. We recognize
a liability for these advance payments in excess of revenue recognized and present it as Contract liabilities
and billings in excess of revenue earned on the balance sheets.
Advanced payment typically is not considered a significant financing
component because it is used to meet working capital demands that
can be higher in the early stages of a contract and to protect us from
the other party failing to adequately complete some or all of
its obligations under the contract. For industrial and consumer purchase
orders, we typically receive payments within 30 to 60 days of
shipment of the product, although for some purchase orders, we may require
advanced payment prior to shipment of the product.
Accounting
for design, development and production contracts requires judgment relative to assessing risks, estimating contract revenues and costs
and making assumptions for schedule and technical issues. Due to the size and nature of the work required to be performed onin many of
our contracts, the estimation of total revenue and cost at completion is complicated and subject to many variables. Contract costs include
material, labor and subcontracting costs, as well as an allocation of indirect costs. We have to make assumptions regarding the number
of labor hours required to complete a task, the complexity of the work to be performed, the availability and cost of materials and performance
by our subcontractors. For contract change orders, claims or similar items, we apply judgment in estimating the amounts and assessing
the potential for realization. These amounts are only included in the contract value when they can be reliably estimated and realization
is considered probable. If our estimate of total contract costs or our determination of whether the customer agrees that a milestone
achievement is incorrect, our revenue could be overstated or understated and the profits or loss reported could be subject to adjustment.
For
our commercial customers, the Company’s revenue is recognized when obligations under the terms of a contract with our customer
are satisfied and the Company transfers control of the products or performsperform services, which is upon delivery of the product
to the customer
or performance of the services. Revenue is recorded as the amount of consideration we expect to receive in exchange for transferring
transferring goods or providing services. Provisions for product returns and allowances are reductions in the transaction price and are
recorded in
the same period as the related revenues. We analyze historical returns, current economic trends and changes in customer demand
when evaluating
the adequacy of sales returns and other allowances. Certain product sales are made to distributors under agreements allowing
for a limited
right of return on unsold products. Sales to distributors are primarily made for sales to the distributors’ customers
and not for
stocking of inventory. Sales, value add and other taxes we collect concurrentconcurrently with revenue-producing activities are excluded
from revenue.
The
Company also licenses its intellectual property (“IP”) through technology license agreements which provides the customer
the right to use our IP as it exists at a point in time. These agreements may include other performance obligations including the sale
of productproducts to the customer. The satisfaction of the Company’s performance obligation, and related recognition of revenue, occurs
when the IP is delivered to the customer, the license period has begun and there are no additional performance obligations in the agreement.
When the license is distinct from other obligations in the agreement, the Company treats the license and other performance obligations
as separate performance obligations. Accordingly, the license is recognized at a point in time or over time based on the standalone selling
price. Under certain license agreements, we may receive royalties based on the sales of the licensed product. We recognize royalty revenue
upon the later of when the related sales occur, or when the performance obligation to which some or all of the royalty has been allocated
has been satisfied (or partially satisfied). Under our current license agreements for which a royalty exists, we have recorded revenue
when the related sales by our customer occursoccur because the performance obligation related to the delivery of the license to the customer
has been satisfied.
We
periodically make equity investments in private companies, accounted for as an equity investment, whose values are difficult to determine.
When assessing investments in private companies for impairment, we consider such factors as, among others, the share price from the investee’s
latest financing round, the performance of the investee in relation to its own operating targets and its business plan, the investee’s
revenue and cost trends, the liquidity and cash position, including its cash burn rate and market acceptance of the investee’s
products and services. Because these are private companies that we do not control we may not be able to obtain all of the information
we would want in order to make a complete assessment of the investment on a timely basis. Accordingly, our estimates may be revised if
other information becomes available at a later date.
Consolidation, Variable Interest Entities, and Deconsolidation of Kopin Europe
We evaluate whether entities in which we hold an ownership or contractual interest should be consolidated in accordance with ASC 810, Consolidation. This evaluation requires significant judgment, including determining whether an entity is a variable interest entity (“VIE”) and, if so, whether we are the primary beneficiary.
On October 16, 2025, following a strategic transaction with Theon International Plc (“Theon”), pursuant to which Theon acquired a 49% equity interest in Kopin Europe Ltd. (“Kopin Europe”) and the parties entered into a shareholder agreement, management reassessed its interest in Kopin Europe under the VIE model. Although we continue to hold a variable interest in Kopin Europe, management concluded that Kopin Europe is a VIE for which we are no longer the primary beneficiary.
This conclusion required significant judgment, particularly in evaluating whether we have the power to direct the activities that most significantly impact Kopin Europe’s economic performance and whether we have the obligation to absorb losses or the right to receive benefits that could be potentially significant. In making this determination, management considered, among other factors, the governance provisions in the shareholder agreement, the substantive decision making rights held by Theon, the nature of the activities that most significantly affect Kopin Europe’s economic performance, and our exposure to Kopin Europe’s economics following the transaction. Decisions regarding those significant activities require the consent of both Kopin and Theon.
As a result of this assessment, Kopin Europe was deconsolidated from our consolidated financial statements, and we recognized a gain on deconsolidation. Our retained interest in Kopin Europe is accounted for under the equity method, and we elected the fair value option for this investment.
Because this assessment involves significant judgment and is sensitive to changes in facts and circumstances, including modifications to governance arrangements, ownership interests, or operating activities, different assumptions or changes in circumstances could result in a different consolidation conclusion in future periods.
We
manufacture Active-matrix Liquid
Crystal (“AMLCD”) transmissivetransmissive. and Liquid Crystal on Silicon (“LCOS”) reflective
microdisplays. Our AMLCD
display production is being performed entirely in our Westborough, Massachusetts facility. KEL, our wholly owned
subsidiary,KEL manufactures our LCOS microdisplays
in its facility located in Scotland. Our OLED displays are designed by us with silicon wafer and manufactured
OLED depostion by third partiesparties,
and forfinal us.assembly and test by us or in some instances by our deposition partners.
Because
our fiscal year ends on the last Saturday of December, every seven years we have a fiscal year with 53 weeks. Our fiscal years 2025
and 2024 and
2023 were 52-week years and fiscal year 2022 was a 53-week year.years.
Revenues.
Our revenues by display application, which include product sales and amounts earned from research and development contracts, for
fiscal years 2024, 20232025 and 20222024 by category, were as follows:
Sales
of our products for Defense applications include systems used by the military both in the field and for training and simulation. Sales
of our products for Defense applications may be for a one-time purchase or for programs that run for several years. Revenues from product
sales to defense customers increaseddecreased in 20242025 compared to 2023,2024, primarily due to ana increasedecrease in shipments of our products for thermal weapon
weapon sight applications that was partially offset by a decrease in sales of our products for defense pilot helmets.applications.
Industrial
applications revenues represent customers who purchase our display products for use in headsets used for manufacturing,
distribution, distribution,
public safety, 3D metrology equipment and other industrial applications. Our 3D metrology customers are primarily
located in AsiaAsia, and
they sell to AsianAsia-based contract manufacturers who use the 3D metrology machines for quality control purposes.
The decrease in Industrial/Enterprise
applications revenues in 2024 compared to 2023 was primarily due to a decrease in sales to customers who use our display components in
3D metrology equipment and industrial headsets.applications Overmarket has seen new entrants over the last few years, we believe our customers have been using lower priced and lower
quality display products in their 3D AOI machines to compensate for lower demand, which has resultedled into moreincreased price competition. We
have are
introducingintroduced lower priced products in 2025 to increasecompete sales,with our competitors, but ifwe unit demand remains flat or decreases, our revenues fromexpect this market
trend will decline.continue and hence we are focusing our
product and selling efforts on other more attractive market segments.
Sales
of our displays for Consumer applications are primarily for use in thermal imaging products, recreational rifle
and hand-held
scopes. The decrease in Consumer applications in 20242025 compared to 20232024 was primarily due to a decrease in sales of our displays for
consumer applications which was partially the result of our focusingre-focusing the Company’s
sales and marketing efforts on defense
applications in 2023.applications.
R&D
revenues decreased in 20242025 as compared to 20232024 primarily due to decreasedthe fundingtiming forof displayboth technology,starts armoredof vehiclenew targeting systems
and other weapon system development for U.S. defense programs,programs and medicalcompletion headsetof development.our existing programs. This variance falls within the
normal ebb and flow of funded programs. These contracts typically reimburse us
for direct costs and allocated overhead and selling, general and administrative costs and in some cases profit. In 20242025 and 2023,2024, our
R&D revenues exceeded funded R&D expenses by approximately $2.2$1.1 million and $6.3$2.2 million, respectively.
International
product sales represented
approximately 6% and 13%5% of product revenues for 20242025 and 2023, respectively.2024. We categorize our revenues as
either domestic or international based upon the
delivery destination of our product. For example, if the customer is located in Asia
or if a U.S. customer has its Asian contract manufacturer
order product from us and we deliver the product to Asia, we categorize both
these sales as international. In addition, if we earn royalties
on sales from a customer, the royalties are categorized as domestic or
international based on how the product revenues are categorized.
Our international sales decreased in 20242025 as compared to 20232024 due mainly to
a decrease in sales of our products for 3D metrology application
by our subsidiary, Kopin Europe Ltd., our OLED displays for consumer
applications and industrial headset products manufactured overseas.Ltd. Our international sales are primarily denominated in U.S. dollars.
Consequently, a strengthening of the U.S. dollar
could increase the price in local currencies of our products in foreign markets and
make our products relatively more expensive than competitors’
products that are denominated in local currencies, which could result
in a reduction in sales or profitability in those foreign markets.
As a result, our financial position and results of operations are
subject to exchange rate fluctuation in transactional and functional
currency. We have not taken any protective measures against exchange
rate fluctuations, such as purchasing hedging instruments with respect
to such fluctuations, because of the historically stable exchange
rate between the Japanese yen, Great Britain pound and the U.S. dollar. Foreign currency translation impact on our results, if material,
is described in further detail under “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” section below.
Revenues
from product sales to defense customers decreased in 2023 compared to 2022, primarily due to a decrease in shipments of our products
for thermal weapon sight applications that was partially offset by an increase in sales of our products for defense pilot helmets and
training and simulation programs.
Revenues
from product sales for industrial/enterprise applications decreased in 2023 compared to 2022 primarily due to a decrease in sales to
customers who use our display components in 3D metrology equipment and industrial headsets.
Revenues
from product sales for consumer applications decreased in 2023 compared to 2022 primarily due to a decrease in sales of our OLED displays
for consumer applications.
R&D
revenues decreased in 2023 as compared to 2022 primarily due to decreased funding for new display technology development for U.S. defense
programs and OLED display development, which was partially offset by increased funding for armor vehicle targeting system and medical
headset development. These contracts typically reimburse us for direct costs and allocated overhead and selling, general and administrative
costs and in some cases profit. In 2023 and 2022, our R&D revenues exceeded funded R&D expenses by approximately $6.3 million
and $4.1 million, respectively.
The
increase in license and royalty revenue in 2023 compared to 2022 is due to an increase in royalties earned under IP license agreements
for industrial wearable headsets.
International
product sales represented approximately 13% and 22% of product revenues for 2023 and 2022, respectively. Our international sales decreased
in 2023 as compared to 2022 due to a decrease in sales of our products for 3D metrology application by our subsidiary, KEL, our OLED
displays for consumer applications and industrial headset products manufactured overseas.
Cost
of Product Revenues. Cost of product revenues, which isare comprised of materials, labor and manufacturing overhead related to the production
of our products for fiscal years 2024, 20232025 and 20222024 were as follows:
Cost
of product revenues decreasedincreased as a percentage of revenues in 20242025 as compared to 20232024 primarily due to increasedlower unitoverhead volumeabsorption due
to lower total product volume, as well as higher one-time write downs of thermalobsolete materials that offset gains in operational
weaponefficiencies. sightsAdditionally, the margin improvements from higherefficiency salesgains inwithin 2024 as compared to 2023 which resulted in a lower fixed overhead cost per unit. The margin improvement
fromour thermal weapon sights wasproduct line were
partially offset by lower margin contribution from industrial and training and simulation revenues due
to their declinelower in2025 sales.
The Company also implemented several programs and hired additional employees to improve manufacturing quality and
and efficiencies.efficiency.
The
United States government is or is in the process of increasing or implementing tariffs on the importation of certain goods. In some
cases, cases,
our contracts allow us to pass along new or increased tariffs subject to ability to prove the impact of the tariff on the
cost of our
product. If we are unable to increase our prices due to the implementation or increase in tariff,tariffs, duties and other
taxes our gross margin
and overall profitability wouldwill be negatively impacted. Furthermore, order intake along with certain
programmatic revenue recognition was hindered by several government shutdowns that imposed significant delays to our 2025 plan.
Several expected orders and subsequent revenue recognition have been delayed into 2026 due to substantial backlogs within the
contracting pipeline.
The
issues associated with the global shortage of semiconductor circuit chips and other raw materials decreased in 20242025 as compared to 2023
and 2022.2024. However, we have identified several semiconductor components which continue to have long lead delivery times. We continue to
search for and procure all necessary components from our current vendors and from new alternative vendors. In certain
situations, we canmay obtain
theprocure alternative components butor procure them at a significantlyan increased cost. The inability to procure a single component will prevent the completion
of our
product and the ability to sell the product. Our products go through extensive qualification processes and therefore our customers
may may
not accept a replacement component. We are unable to determine if we will be able to obtain all necessary components for fiscal 2025.2026.
If we are unable to obtain all necessary components, we may be required to stop production, which would negatively affect our cash flow
and results of operations.
Cost
of product revenues decreased as a percentage of revenues in 2023 as compared to 2022 primarily due to increased sales of higher margin
products for defense applications in 2023 versus 2022 and lower sales of lower margin products from defense applications in 2023 versus
2022. The Company also implemented several programs and hired additional employees to improve manufacturing quality and efficiency.
Research
and Development. Research and development (“R&D”) expenses are incurred in support of internal display
development programs or programs funded by agencies
or prime contractors of the U.S. Government and commercial partners. R&D
costs include staffing, purchases of materials and laboratory
supplies, circuit design costs, fabrication and packaging of display
products and allocated overhead. In fiscal year 2024,2025, our Funded
R&D expenditures were primarily related to our display products
and defense systemssystems, and our Internal R&D was primarily related
to the development of OLED displays. R&D expenses for fiscal
years 2024, 20232025 and 20222024 were as follows:
Funded R&D expense for 2025 decreased as compared to 2024 primarily due to decreased spending on U.S. defense programs and programs previously in development are transitioning into production. Internal R&D expense for 2025 increased as compared to 2024 primarily due to an increase in internally developed technology focused on future process improvement. During the second half of 2025 we were awarded a $15.4 million Other Transaction Agreement (“OTA”) from the Office of the Secretary of War (“OSW”) through the U.S. Army Contracting Command (“ACC”) under the Industrial Base Analysis and Sustainment (“IBAS”) program. This contract is for the first stages of enablement for domestic microLED production and development of ultra-bright, full-color MicroLED displays optimized for ground soldier augmented reality (“AR”) applications. As a result of this contract and other contracts we have received, we believe funded research and development expenses will increase in fiscal year 2026 as compared to fiscal year 2025.
Funded
R&D expense for 2024 decreased as compared to 2023 primarily due to the completion of contracts for defense programs awarded prior
to 2024. Internal R&D expense for 2024 increased as compared to the prior year primarily due to increases in display development
costs and costs incurred to establish European foundry services.
Funded
R&D expense for 2023 decreased as compared to 2022 primarily due to the completion of contracts for defense programs awarded prior
to 2023. Internal R&D expense for 2023 decreased as compared to the prior year primarily due to decreased OLED development.
Selling,
General and Administrative. Selling, general and administrative (“SG&A”) expenses consist of the expenses incurred
by our sales and marketing personnel and related expenses, and administrative and general corporate expenses. SG&A expenses for the
fiscal years 2024, 20232025 and 20222024 were as follows:
SG&A
for 2024 increased as compared to 2023 primarily due to an increase of
approximately $1.4 million in legal and professional fees and $0.2 million in excise taxes, partially offset by $0.4 million lower bad
debt expense and $0.2 million decrease in non-cash stock-based compensation.
SG&A
for 20232025 increased asdecreased compared to 20222024 primarily due to ana increasedecrease of approximately $5.0$6.4 million in legal and professional fees and
$1.0 $0.1 million in non-cash stock-based compensation, partially offset by a $1.3 million decrease in compensation and benefits.professional
fees.
Litigation Damages. Litigation damages were accrued as a result of the April 22, 2024, jury verdict that was entered against the Company awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. On September 5, 2025, Kopin received a judgment from the courts in the BlueRadios litigation awarding BlueRadios $19.7 million in damages but denying permanent injunction and prejudgment interest. This most recent judgment also provides for the accrual of interest of less than $0.1 million per month until the final settlement. As a result, the accrued litigation damages were reduced by $5.1 million in fiscal year 2025. We also recognized approximately $0.3 million of litigation damages related to the interest on the judgment in fiscal year 2025.
Litigation Damages Fiscal year
2024. Litigation damages were accrued as a result of the April 22, 2024 jury verdict that was entered against the Company awarding
approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages.
Total
Non-operating Income (Expense).
Non-operating Income. Non-operatingIncome (expense) income is primarily composed of interest income, revaluation and impairment
of equity investments, foreign
currency transactions, remeasurementgain gainsdue to the Deconsolidation of Kopin Europe Ltd, as defined and lossesdiscussed incurredin byNote our UK-based subsidiaries1. and other non-operating
non-operating income items. Non-operating income (expense) income for the fiscal years 2024, 20232025 and 20222024 were as follows:
In
2024, 2025, we recorded $1.6$11.1 million gain
on deconsolidation and $0.8 million of impairment losses on equity investments. In 2023,2024, we recorded $3.3$1.6 million of impairment losses
on on
equity investments. In 2024,2025, we recorded $0.2$0.3 million ofin foreign currency gains compared to $0.2 million of foreign currency lossesgains
recorded recorded
in 2023.2024.
In
2023, we recorded $3.3 million of impairment losses on equity investments. In 2022, we recorded a gain of $4.7 million resulting from
the revaluation of an equity investment. Also in 2022, we recorded a $2.0 million impairment charge on an equity investment. In 2023,
we recorded $0.2 million of foreign currency losses compared to $0.3 million of foreign currency losses recorded in 2022.
The
provision for income taxes for the fiscal years ended 2023 and 2022 of approximately $(0.2) million and $(0.1) million, respectively,
was due to the accretion of additional potential liabilities related to uncertain tax positions and deferred tax liabilities for the
Company’s former Korean subsidiary.
Net
loss attributable to noncontrolling interest. In the first quarter of 2023, we acquired the remaining interest in eMDT. Net loss
attributable to noncontrolling interest on our consolidated statement of operations represents the portion of the results of operations
of our majority owned subsidiaries which is allocated to the shareholders of the equity interests not owned by us. The change in net
loss attributable to noncontrolling interest in 2024 compared to 2023 was $0 and in 2023 compared to 2022 was less than $0.1 million
and was the result of operations of eMDT.
The increase in cash, cash equivalents, and restricted cash for the twelve months ended December 27, 2025 was primarily due to proceeds from the sales of marketable securities of $36.4 million, proceeds from issuance of preferred stock of $6.7 million partially offset by purchases of marketable securities of $15.2 million, cash used in operations of $15.5 million, capital expenditures of $1.4 million and proceeds from the sale of an equity investment of $0.3 million. For the twelve months ended December 27, 2025, cash used in operating activities consisted of net income of $2.6 million, net cash used to fund changes in operating assets and liabilities of $6.3 million, and non-cash charges totaling $11.9 million, which was primarily related to accrued litigation damages offset by stock-based compensation, inventory reserves, depreciation, and investment impairment net of unrealized gains. We expect that net cash used for or provided by operating activities to fluctuate based on our operating results.
Litigation damages were accrued as a result of the April 22, 2024, jury verdict that was entered against the Company awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. On September 5, 2025, Kopin received a judgment from the courts in the BlueRadios litigation awarding BlueRadios $19.7 million in damages but denying permanent injunction and prejudgment interest. This most recent judgment also provides for the accrual of interest of less than $0.1 million per month until the final settlement. As a result, the accrued litigation damages were reduced by $5.1 million in fiscal year 2025. We also recognized approximately $0.3 million of litigation damages related to the interest on the judgment in fiscal year 2025. On October 2, 2025, the Company posted a supersedeas bond for $23.0 million which consisted of the $19.7 million judgement, legal expenses, and interest that would accrue over the expected term of the Company’s appeal to the verdict.
The
change in cash and cash equivalents and marketable securities was primarily due to the sale of common stock and prefunded warrants of
$1.5 million in the fourth quarter of 2024, $25.2 million in the third quarter of 2024 and $7.2 million in the first quarter of 2024
which was partially offset by cash used in operations of $14.2 million. Our cash and cash equivalents and liquidity could be adversely
affected by any amounts that become payable in connection with any adverse results from any litigation we are, or may become, involved
in.
On
September 23, 2024, we sold 37,550,000 shares of common stock and pre-funded warrants to purchase up to 4,000,000 shares of common stock
at a public offering price of $0.65 per share. In addition, in lieu of
common stock to certain investors, we offered pre-funded warrants to purchase 4,000,000 shares of our common stock at a purchase price
of $0.64 per pre-funded warrants,warrant, forwhich equals the public offering price per share of the common stock less the $0.01 exercise price per
share of each pre-funded warrant. We received gross proceeds of $27.0 million before deducting underwriting discounts
and offering expenses
paid by the us of $1.8 million. TheIn offeringaddition, pricewe ofgranted the pre-fundedunderwriters warranta equals30-day option to purchase up to an additional 6,232,500 shares
of common stock at the public offering price per
share of the common stockprice, less theunderwriting $0.01discounts perand share exercise price of each pre-funded warrant.commissions.
On September 29, 2025, the Company entered into a securities purchase agreement (the “Purchase Agreement”) for a private investment in public equity financing (the “PIPE”) for 19,545,950 shares of its common stock, par value $0.01 per share (the “Shares”). The net proceeds to the Company from the offering were approximately $38.1 million, after deducting placement agent fees and commissions and estimated offering expenses payable by the Company. The transaction was consummated on September 30, 2025.
On October 16, 2025, the Company completed a $15 million strategic investment with Theon International Plc. Under the terms of the Agreements, Theon acquired a 49% interest in Kopin’s subsidiary, Kopin Europe Ltd. for $8.0 million and the parties entered into a licensing and development agreement and funding agreements relating to the joint development of military products. In addition, Theon purchased $7.0 million worth of shares of Series A Convertible Preferred Stock, par value $0.01 per share, of the Company (the “Preferred Stock”). Each share of the Preferred Stock is convertible into shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”) at an initial fixed conversion price of $3.00 per share, pursuant to the terms of the Certificate of Designation for Series A Convertible Preferred Stock of the Company (the “Certificate of Designations”). The Company will have the ability to force the conversion of the preferred stock into common stock once the Company’s common stock trades at $5.50 per share or higher for 10 Trading Days (as defined in the Certificate of Designation) within a 30 consecutive Trading Day period. The Preferred Stock will carry an annual dividend of at the base rate dividend rate of 4%, 2% payable in cash and 2% payable in stock. With the close of this transaction, Kopin Europe Ltd. was deconsolidated from the Company’s consolidated financial statements. The consolidated statement of operations therefore includes nine months and sixteen days of activity related to Kopin Europe Ltd. The assets and liabilities of Kopin Europe Ltd. are no longer included within the Company’s consolidated balance sheets. Any discussions related to results, operations, and accounting policies associated with Kopin Europe Ltd. are referring to the current period through this transaction and prior periods as consolidated.
On
January 27, 2023, we sold 17 million shares of registered common stock to certain investors and issued pre-funded warrants to purchase
up to 6,000,000 shares of common stock at a public offering price of $0.99 per pre-funded warrant, which equals the public offering price
per share of the common stock less the $0.01 per share exercise price of each pre-funded warrant. The gross proceeds of these transactions
were $22.9 million, before deducting underwriting discounts and offering expenses paid by us of $1.5 million.
During
the three months ended March 30, 2024, we sold 3,080,000 shares of common stock for gross proceeds of $7,466,755 (average of $2.42 per
per share) before deducting broker expenses paid by us of approximately $0.2 million, pursuant to our then effective At-The-Market Equity
Equity Offering Sales Agreement, dated as of March 5, 2021 (the “ATM Agreement”) with Stifel, Nicolaus & Company, Incorporated
Incorporated (“Stifel”), as agent. The ATM Agreement terminated in the three months ended March 30, 2024. On January 24,
2025 2025, we entered
into a new At-The-Market Equity Offering Sales Agreement with Stifel, Nicolaus & Company, Incorporated
(“Stifel”), as
agent, for the sale of up to $50 million of securities. Subsequent to year end, the Company cannot use
the ATM Agreement entered into on January 24, 2025 until such time the Company can utilize Form S-3.
In the second quarter of 2022,
we sold 1.5 million shares of common stock and 0.2 million shares of treasury stock for gross proceeds of $2.1 million (average of $1.26
per share) before deducting broker expenses paid by us of less than $0.1 million and in the third quarter of 2022, the Company sold 675,000
shares of common stock for gross proceeds of approximately $0.9 million (average of $1.27 per share) before deducting broker expenses
paid by us of less than $0.1 million, pursuant to an ATM Agreement. The net proceeds from the sale of common shares were used for general
corporate purposes, including working capital.
The domestic locations balance of $61.6 million for the fiscal year ended 2025 includes $25.3 million of restricted cash that is not available for current operating use.
We
have no plans to repatriate the cash and cash equivalents held in our foreign subsidiary KEL.
We
have incurredhad net lossesincome of of $2.6
million in fiscal year 2025 and a net loss of $43.9 million, $19.7 million and $19.3 million for thein fiscal yearsyear 2024, 2023 and 2022, respectively,
and net cash outflows from operations of $14.2 million, $15.3 $15.5
million and $17.7$14.2 million for the fiscal years ended 2024, 20232025 and
2022, 2024, respectively. Our net cash outflows from operations were
partially a result of funding our ongoing investments in research and
development which we believe will continue. WeHowever, havethe Company raised approximately $45.8 million during the fiscal year ended December 27, 2025, through the issuance of common
stock, pre-funded warrants and preferred stock. Moreover, the Company has posted a bond to satisfy the court’s verdict of $19.7
million in damages and anticipated accrued interest in the pastmatter soldof equityBlueRadios securitiesvs. throughKopin anCorporation, at-the-marketInc. offeringshould the Company’s
appeal be unsuccessful (refer to Note 14 of our consolidated financial statements for more information). As of December 27, 2025, the
Company had $36.4 million cash and incash the
traditionalequivalents fashion(excluding ofrestricted significantcash), equity offerings. Aswhich the Company believes is unablesufficient to concludesupport
its that a favorable outcome in this
litigation is probableoperations and duesatisfy toits obligations for at least the net losses and negative cash flows from operations, management has concluded that there is
substantial doubt about the Company’s ability to continue as a going concern fornext twelve months from the issuancedate of these
financialthis statements.filing. Excluding a possible adverse result of the litigation discussed in Note 12 of the consolidated financial
statements, weWe estimate we will have sufficient liquidity to fund operations at least through the end of the second quarter of 2026.2027. Nonetheless,
Nonetheless, we monitor the capital markets on an ongoing basis and may consider raising capital if favorable market conditions
develop. If our actual
results are less than projected or we need to raise capital for additional liquidity, we may be required to
do additional equity financings, financing,
reduce expenses or enter into a strategic transaction. However, we can make no assurance that we
will be able to raise additional capital,
reduce expenses sufficiently, or enter into a strategic transaction on terms acceptable to
us, or at all.all
What changed in the latest 10-Q
Risk Factors
Our business and financial results are subject to numerous risks and uncertainties. As a result, the risks and uncertainties discussed in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended December 27, 2025, should be carefully considered. There have been no material changes in the assessment of our risk factors from those set forth in our Annual Report on Form 10-K for the fiscal year ended December 27, 2025.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
Funded R&D expense for the three and six months endedsee in full comparisonMarchJune29,27, 2026 increased as compared to the three and six months endedMarchJune29,28, 2025 primarily due to the Company’s government grant for the development of ultra-bright, full color MicroLED displays optimized for ground soldier augmented reality applications. Funded R&D expense includes costs related to grant and collaboration income. Internal R&D expense decreased for the three and six month ended June 27, 2026 as compared to the three and six months ended June 28, 2025decreasedprimarily due toanlowerincreaselaborinhoursprocessspentimprovements.on internal research and development activities.
“The increase in cost of product revenues as a percentage of net product revenues for the three months ended March 28, 2026, compared to the three months ended March 29, 2025, was primarily attributable to reduced production efficiency and lower production volume. The Company believes the negative 3% product gross margin for the three months ended March 28, 2026 was an uncommon occurrence related to events in the quarter that we do not expect to reoccur. …”see in full comparison
“Net Income (Loss). We had a net income of $0.8 million and a net loss of $2.9 million during the three and six months ended June 27, 2026, respectively compared to net losses of $5.2 million and $8.3 million during the three and six months ended June 28, 2025. The decrease in the net loss during the three months ended June 27, 2026 compared to the three months ended June 28, 2025 was due to gains on investments of $2.3 million, a $2.1 million tax credit, and increase in total revenues. …”see in full comparison
For thesee in full comparisonthreesix months endedMarchJune 27, 2026 and June 28,2026,2025, cash used in operating activities consisted primarily of a netlosslosses from operations of$3.8$2.9 million andnetcash$8.3frommillionchanges in operating assets and liabilities of $4.7 million, which were partially offset by non-cash charges totaling $1.8 million, which was primarily related to stock-based compensation, and depreciation.respectively. For thethreesix months endedMarchJune28,27, 2026, net cash used in investing activities in the amount of$1.3$5.1 million consisted of capital expenditures. For thethreesix months endedMarchJune29,28, 2025 cash provided by investing activities was primarily related to net proceeds from the sale of marketable securities. We expect that net cash used for or provided by operating activities to fluctuate in future periods as a result of a number of factors, including fluctuations in our operatingresults, the timing of when we recognize revenue,results and changes in components of working capital. Our cash and cash equivalents and liquidity could be adversely affected by any amounts that become payable in connection with any adverse results from any litigation we are, or may become, involvedinvolvedin. The change in financing activities was the settlements of restricted stock for tax witholding obligations for $1.1 million.
“On May 28, 2026 Theon exercised its conversion right under the Certificate of Designation to convert all 1,000 outstanding shares of Series A Convertible Preferred stock into shares of Common Stock. The conversion was effected at a conversion price of $3.00 per share resulting in the issuance of 2,380,973 shares of the Company’s common stock to Theon. The Company’s Series A Convertible Preferred stock has been retired and no shares of Series A Convertible Preferred Stock are outstanding.”see in full comparison
R&D revenues increasedsee in full comparisonslightlyin the three and six months endedMarchJune28,27, 2026 as compared to the three and six months endedMarchJune29,28, 2025 primarily duedueto thetimingCompany’sofprogressbothonstartstheofPhasenew2programsOff-the-Visor Heads-Up Display program with the U.S. Army andcompletiondueof our existing programs. This variance falls withinto thenormalstartebbof the development program with Fabric.AI entered into on April 27, 2026 to develop andflowcommercialize certain GPU to GPU connectivity technologies.of funded programs.These contracts typically reimburse us for direct costs and allocated overhead and selling, general and administrative costs and in some cases profit.
Full comparison: every changed paragraph (28)
Revenues.
For the three and six months ended MarchJune 28,27, 2026 and MarchJune 29,28, 2025, our revenues by display application, which include product sales
and and
amounts earned from research and development contracts (“R&D”), were as follows:
Sales
of our products for Defense applications include systems used by the military both in the field and for training and simulation. Sales
of our products for Defense applications may be for a one-time purchase or for programs that run for several years. Revenues from product
sales to defense customers decreasedincreased in the three months ended MarchJune 28,27, 2026 as compared to the three months ended MarchJune 29,28, 2025, primarily
due to lowerhigher production volumes of our products for thermal weapon sight applications and liquid crystal displays. The decrease in Defense
applications revenues in the six months ended June 27, 2026 as compared to the six months ended June 28, 2025 was primarily related to
a decrease in revenue from products used in thermal weapon sights and liquid crystal displays.
Industrial
applications revenues represent customers who purchase our display products for use in headsets used for manufacturing, distribution,
public safety, 3D metrology equipment and other industrial applications. Our 3D metrology customers are primarily located in Asia, and
they sell to Asia-based contract manufacturers who use the 3D metrology machines for quality control purposes. The industrial applications
market has seen new entrants over the last few years, which has led to increased price competition. We have introduced lower priced products
in 2025 to compete with our competitors, but we expect this trend will continue and hence we are focusing our product and selling efforts on
on other more attractive market segments.
R&D
revenues increased slightly in the three and six months ended MarchJune 28,27, 2026 as compared to the three and six months ended MarchJune 29,28, 2025 primarily
due due
to the timingCompany’s ofprogress bothon startsthe ofPhase new2 programsOff-the-Visor Heads-Up Display program with the U.S. Army and completiondue of our existing programs. This variance falls withinto the normalstart ebbof
the development program with Fabric.AI entered into on April 27, 2026 to develop and flowcommercialize certain GPU to GPU connectivity technologies.
of funded programs. These contracts typically reimburse us for direct costs and allocated overhead and selling, general and administrative
costs and in some
cases profit.
The
slight decreaseincrease in license and royalty revenue in the three months ended MarchJune 28,27, 2026 as compared to the three months ended MarchJune 29,28,
2025 is due to a decreaseincrease in royalties earned under IP license agreements for industrial wearable headsets.
Grant
revenues increased in the three and six months ended MarchJune 28,27, 2026 as compared to the three and six months ended MarchJune 29,28, 2025 in connection
with the
Company’s government grant, awarded in the fourth quarter of 2025, for the development of ultra-bright, full color MicroLED
displays optimized
for ground soldier augmented reality applications.
Collaboration
revenues increased in the three and six months ended MarchJune 28,27, 2026 as compared to the three and six months ended MarchJune 29,28, 2025 as a result
of the Company’s
strategic partnership, initiated in the fourth quarter of 2025, to develop the next generation clip on with augmented
reality and thermal integration
capabilities based on the Company’s micro-display technology.
Cost
of Product Revenues. Cost of product revenues, which is comprised of materials, labor and manufacturing overhead related to the production
of our products for the three and six months ended MarchJune 28,27, 2026 and MarchJune 29,28, 2025 were as follows:
The decrease in cost of product revenues as a percentage of net product revenues for the three months ended June 27, 2026, compared to the three months ended June 28, 2025, was primarily attributable to product mix. Cost of product revenues as a percentage of net product revenues increased during the six months ended June 27, 2026 as compared to the six months ended June 28, 2025 primarily attributable to reduced production efficiency during the first three months of 2026.
The
increase in cost of product revenues as a percentage of net product revenues for the three months ended March 28, 2026, compared to the
three months ended March 29, 2025, was primarily attributable to reduced production efficiency and lower production volume. The Company
believes the negative 3% product gross margin for the three months ended March 28, 2026 was an uncommon occurrence related to events in the quarter that we do not expect to reoccur.
The Company expects a combination of customer price increases on follow-on customer purchase orders and improvements in production efficiency
will result in positive product margins in future periods.
Research
and Development. R&D expenses are incurred in support of internal display development programs and programs funded by agencies
or prime contractors of the U.S. Government and commercial partners. R&D costs include staffing, purchases of materials and laboratory
supplies, circuit design costs, fabrication and packaging of display products, and overhead. In fiscal year 2026, we expect our R&D
expenditures to be related to our display products, overlay weapon sights and OLED display technologies. R&D expenses for the three
and six months ended MarchJune 28,27, 2026 and MarchJune 29,28, 2025 were as follows:
Funded
R&D expense for the three and six months ended MarchJune 29,27, 2026 increased as compared to the three and six months ended MarchJune 29,28, 2025
primarily due
to the Company’s government grant for the development of ultra-bright, full color MicroLED displays optimized for
ground soldier
augmented reality applications. Funded R&D expense includes costs related to grant and collaboration income. Internal
R&D expense decreased for the three and six month ended June 27, 2026 as compared to the three and six months ended June 28, 2025
decreasedprimarily due to anlower increaselabor inhours processspent improvements.on internal research and development activities.
Selling,
General and Administrative. Selling, general and administrative (“SG&A”) expenses consist of the expenses incurred
by our sales and marketing personnel and related expenses, and administrative and general corporate expenses. SG&A expenses for the
three and six months ended MarchJune 28,27, 2026 and MarchJune 29,28, 2025 were as follows:
SG&A
increased for the three and six months ended MarchJune 28,27, 2026 as compared to the three and six months ended MarchJune 29,28, 2025 primarily due
to increases in
professional fees and accrued performance-based compensation.
Other
Income, net. Other income, net, is primarily composed of interest income, foreign currency transactions, gains on fair value
recording recording
of investments and other non-operating income items. Other income, net, for the three and six months ended MarchJune 27, 2026
and June 28, 20262025 and March 29, 2025
were as follows:
During
the three and six months ended MarchJune 28,27, 2026, we had a gaingains on an investmentinvestments of approximately $2.3 million.million and $4.6 million, respectively.
During the three months ended March
29,June 2025,27, we sold an investment for a gain of approximately $0.3 million and had2026, interest income ofdecreased approximately $0.4$0.2 million.million compared to the three months ended
June 27, 2025.
Tax
Provision. We recorded a provision for income taxes of less than $0.1 million in the three months ended March 28, 2026 and
March 29, 2025, respectively.
NetTax
Loss.Provision. We incurredrecorded a netbenefit lossfor income taxes of $3.8approximately $2.1 million duringin the three months ended MarchJune 28,27, 2026 compareddue to a net lossthe
expiration of $3.1the statute of limitation of an uncertain tax position. We recorded a provision for income taxes of approximately $0.1 million
duringfor the three and six months ended MarchJune 29,28, 2025.
Net Income (Loss). We had a net income of $0.8 million and a net loss of $2.9 million during the three and six months ended June 27, 2026, respectively compared to net losses of $5.2 million and $8.3 million during the three and six months ended June 28, 2025. The decrease in the net loss during the three months ended June 27, 2026 compared to the three months ended June 28, 2025 was due to gains on investments of $2.3 million, a $2.1 million tax credit, and increase in total revenues. The decrease in the net loss during the six months ended June 27, 2026 compared to the six months ended June 28, 2025 was primarily due to a gain on investments.
On
MarchJune 28,27, 2026 and December 27, 2025, we had cash and cash equivalents, including restricted cash, and marketable securities of $59.5$50.3
million and working capitalcapital, excluding restricted cash, of $25.6$17.5 million compared to $61.6 million and $33.6 million, respectively.
For
the threesix months ended MarchJune 27, 2026 and June 28, 2026,2025, cash used in operating activities consisted primarily of a net losslosses from
operations of $3.8$2.9 million and
net cash$8.3 frommillion changes in operating assets and liabilities of $4.7 million, which were partially offset by non-cash charges totaling $1.8
million, which was primarily related to stock-based compensation, and depreciation.respectively. For the threesix months ended MarchJune 28,27, 2026, net cash used in investing
activities in the amount of $1.3$5.1 million consisted
of capital expenditures. For the threesix months ended MarchJune 29,28, 2025 cash provided by
investing activities was primarily related to net
proceeds from the sale of marketable securities. We expect that net cash used for
or provided by operating
activities to fluctuate in future periods as a result of a number of factors, including fluctuations in our
operating results, the timing
of when we recognize revenue,results and changes in components of working capital. Our cash and cash equivalents and liquidity could be adversely
affected by any amounts that become payable in connection with any adverse results from any litigation we are, or may become,
involved involved
in. The change in financing activities was the settlements of restricted stock for tax witholding obligations for $1.1 million.
On
October 16, 2025, the Company completed a $15 million strategic investment with Theon Under the terms of the Agreements, Theon acquired
a 49% interest in Kopin’s subsidiary, Kopin Europe Ltd. for $8.0 million and the parties entered into a licensing and development
agreement and funding agreements relating to the joint development of military products. In addition, Theon purchased $7.0 million worth
of shares of Series A Convertible Preferred Stock, par value $0.01 per share, of the Company (the “Preferred Stock”). Each
share of the Preferred Stock iswas convertible into shares of common stock, par value $0.01 per share, of the Company (the “Common
Stock”) at an initial fixed conversion price of $3.00 per share, pursuant to the terms of the Certificate of Designation for Series
A Convertible Preferred Stock of the Company (the “Certificate of Designations”). The Company will havehad the ability to force
the conversion of the preferred stock into common stock once the Company’s common stock trades at $5.50 per share or higher for
10 Trading Days (as defined in the Certificate of Designation) within a 30 consecutive Trading Day period. The Preferred Stock will carrycarried
an annual dividend of at the base rate dividend rate of 4%, 2% payable in cash and 2% payable in stock. With the close of this transaction,
Kopin Europe Ltd. was deconsolidated from the Company’s consolidated financial statements. The consolidated statement of operations
therefore includes nine months and sixteen days of activity related to Kopin Europe Ltd. The assets and liabilities of Kopin Europe Ltd.
are no longer included within the Company’s consolidated balance sheets. Any discussions related to results, operations, and accounting
policies associated with Kopin Europe Ltd. are referring to the current period through this transaction and prior periods as consolidated.
On May 28, 2026 Theon exercised its conversion right under the Certificate of Designation to convert all 1,000 outstanding shares of Series A Convertible Preferred stock into shares of Common Stock. The conversion was effected at a conversion price of $3.00 per share resulting in the issuance of 2,380,973 shares of the Company’s common stock to Theon. The Company’s Series A Convertible Preferred stock has been retired and no shares of Series A Convertible Preferred Stock are outstanding.
The
following table presents the components of our cash, cash equivalents, restricted cash and marketable securities held in U.S. dollars
as of the dates presented:
The
domestic locations balance of $59.5$50.3 million and $61.6 million for the period ended MarchJune 28,27, 2026 and fiscal year ended 2025 includes
$25.4 million and $25.3 million of restricted cash as of June 27, 2026 and December 27, 2025 respectively, that is not available for
current operating use.
The
manufacturing operations at our Korean facility, Kowon, have ceased and Kowon was liquidated at fiscal year ended 2018. WeAs haveof December
27, 2025 we had recorded
deferred tax liabilities for any additional withholding tax that may be due to the Korean government upon Kowon’s
final tax return acceptance. The statue of limitations expired during the three months ended June 27, 2026 and reversed the deferred
acceptance.tax liability of $2.1 million as of June 27, 2026.
We
expect to expend between $3.0$5.0 million and $5.0$6.5 million on capital expenditures in the second half of 2026.
We
had net income of $0.8 million and a net loss of $3.8$2.9 million for the three and six months ended MarchJune 28,27, 2026 and a net loss of $3.1 $2.6
million in fiscal year 2025, and net
cash outflows used in operations of $0.8$5.1 million and $3.4$15.5 million for the threesix months ended March 28,June
27, 2026 and for the fiscal year ended
2025, respectively. Moreover, the Company has posted a bond to satisfy the court’s verdict
of $19.7 million in damages and anticipated
accrued interest in the matter of BlueRadios vs. Kopin Corporation, Inc. should the Company’s
appeal be unsuccessful (refer to
Note 1617 of our consolidated financial statements for more information). As of MarchJune 28,27, 2026, the Company
had $34.1$24.9 million of cash and
cash equivalents (excluding restricted cash), which the Company believes is sufficient to support its operations
and satisfy its obligations
for at least the next twelve months from the issuance of these financial statements. We estimate we will
have sufficient liquidity to
fund operations into the thirdfourth quarter of 2027. Nonetheless, we monitor the capital markets on an ongoing
basis and may consider raising
capital if favorable market conditions develop. If our actual results are less than projected or we need
to raise capital for additional
liquidity, we may be required to do additional equity financing, reduce expenses or enter into a strategic
transaction. However, we can
make no assurance that we will be able to raise additional capital, reduce expenses sufficiently, or enter
into a strategic transaction
on terms acceptable to us, or at all.
KOPN insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 6 filings (2 insiders, 6 trade dates, 524,760 shares, about $1.8M; 6 of these filings say the sales were made under a Rule 10b5-1 trading plan). Net open-market shares: -524,760 (purchases minus sales); net value about -$1.8M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Walsh Paul V Jr |
Grant/award | 64,500 | — | — |
| 2026-06-10 | Nieuwsma David J |
Grant/award | 64,500 | — | — |
| 2026-06-10 | Avery Jill Janice |
Grant/award | 64,500 | — | — |
| 2026-06-10 | Seif Margaret K |
Grant/award | 64,500 | — | — |
| 2026-05-06 | Baker Paul Christopher |
Open-market sale |
58,939 | $4.90 | $288.8K |
| 2026-05-05 | Baker Paul Christopher |
Open-market sale |
1,041 | $4.90 | $5.1K |
| 2026-04-28 | Baker Paul Christopher |
Open-market sale |
116,860 | $3.95 | $461.6K |
| 2026-04-17 | Murray Michael Andrew |
Open-market sale |
96,800 | $3.01 | $291.4K |
| 2026-04-15 | Murray Michael Andrew |
Open-market sale |
63,200 | $3.01 | $190.2K |
| 2026-04-13 | Murray Michael Andrew |
Open-market sale |
187,920 | $2.80 | $526.2K |
Well-known investors holding KOPN (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 2,302,690 | $10.3M | 0.01% | Added 4095% |
| Millennium Management (Israel Englander) | 2026-06-30 | 825,215 | $3.7M | 0.0% | Added 495% |
| Renaissance Technologies | 2026-06-30 | 255,800 | $1.1M | 0.0% | New position |
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 77,064 | $345.2K | 0.0% | Reduced 86% |
| AQR Capital Management (Cliff Asness) | 2026-06-30 | 75,564 | $338.5K | 0.0% | Reduced 51% |
| D. E. Shaw & Co. | 2026-06-30 | 74,848 | $335.3K | 0.0% | New position |